The next important step is to turn these scientific findings into clinical be used be used for early oral cancer detection http://stenhård.com/viagra/ . Annual Meeting of the American Association for Dental Research, is Wong team of researchers for the first time that she developed a standardized Saliva RNA Test for Oral Cancer ready for clinical use reporting. The Saliva RNA Test has been tested in 100 oral cancer and healthy people, and it was confirmed that four saliva oral cancer RNA biomarkers high precision determines oral cancer, will be around 82 percent. This is the first standardized saliva-based test for clinical oral cancer detection and tremendous clinical significance in reducing the mortality and morbidity for oral cancer patients, and have been improving their quality of life.
Currently, clinical test for saliva-Based Oral Cancer Detection: Ready NowOral cancer is the 6th most common cancer in men and the 14th common cancer in women. In the U.S., oral cancer will be diagnosed in an estimated 30,000 Americans this year and cause more than 8,000 deaths. The disease kills about one person per hour. Oral cancer can spread quickly. The majority of oral cancers are diagnosed in late stages, which accounts for the high death rates. Only half of all patients diagnosed with the disease are survive more than five years. However, if the cancer is detected early, there is an 80 to 90 percent chance of survival. It is therefore very important to oral cancer as early as possible to recognize if it can be treated successfully, so the survival rate.
Courtesy to may whole Kaiser Daily Health Policy is Report display, J.earch the archives or sign up for mail service at Emperor Daily Health policy coverage strongly in favor imperial network. A free service of The Henry J. Released. Henry J. Kaiser Family foundatio 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.